Toronto, Canada (PRWEB) September 07, 2012
At this stage of the clinical trial, the Sponsor has initiated sites, patients are being screened, enrolled, randomized and treated. The CTM and CDM group are completing their tasks smoothly. When things are running smoothly, no thoughts are given to fine tuning the system to how users interpret the protocol or how the system is used across different sites.
Then comes the dreaded protocol amendment which may change everything that has been established: (i) inclusion/exclusion criteria, (ii) study assessments, (iii) treatment group assignment, (iv) interim analyses, to name a few.
Topics covered include:
What you will learn:
For more information or to register go to http://xtks.in/xto-503.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Karen Lim (416) 977-6555 ext 227